Latest Muscle relaxants Stories
By Bennett, W R Murray Wilson, Lawrence G; Roy-Byrne, Peter P Abstract- GHB is an increasingly popular drug of abuse that can be associated in select cases with growing dependence and a severe withdrawal syndrome.
By Bill Berkrot NEW YORK (Reuters) - An experimental insomnia drug being developed by Merck & Co. and Danish drug maker H. Lundbeck A/S showed promise in helping patients achieve deep sleep in small mid-stage clinical studies, the companies said on Wednesday.
No single sleeping pill stands out as the best, according to a U.S. review of the newer sleep aids on the market.
NEW YORK (Reuters Health) - While sedative drugs, such as Restoril and Ambien, may improve sleep in older people with insomnia, the risks of such therapy may outweigh the benefits, according to investigators in Canada.
The investigational drug ramelteon reduced the time it took for people with chronic insomnia to fall asleep and also increased their total sleep time, according to the results of a Phase III study sponsored by the drug's maker, Takeda Pharmaceuticals.
Ramelteon, a novel investigational compound under review with the FDA for the treatment of insomnia, reduced the time it took to fall asleep and increased total sleep time in adults with chronic insomnia, according to results from a Phase 3 study presented this week at the 19th Annual Meeting of the Associated Professional Sleep Societies (APSS). Results of the study also showed no evidence of rebound insomnia, next-day impairments or withdrawal effects due to discontinuation.
A team of researchers from the Department of Biochemistry and Molecular Biology and the Institute of Neuroscience at the Universitat AutÃ²noma de Barcelona has discovered that tetanus toxin, which causes tetanus, could be extremely useful as a therapy against psychological disorders such as depression, anxiety and anorexia, and to slow the progress of neurodegenerative disorders such as Parkinson's disease.